Medicare Enrolled

Dr. Vivek Mittal, M.D.

Hepatology Physician · Fresno, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
7045 N MAPLE AVE STE 101, Fresno, CA 93720
5599004013
In practice since 2007 (19 years)
NPI: 1396888277 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mittal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mittal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mittal

Dr. Vivek Mittal is a hepatology physician in Fresno, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mittal performed 834 Medicare services across 617 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mittal received a total of $57,712 from 38 pharmaceutical and/or device companies across 599 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hepatology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mittal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 41% volume in CA $57,712 industry payments

Medicare Practice Summary

Medicare Utilization ↗
834
Medicare services
Top 41% in CA for hepatology physician
617
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~44 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
484 $67 $194
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
101 $63 $960
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
97 $70 $282
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
44 $84 $1,102
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
41 $162 $851
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
35 $179 $1,148
Upper endoscopy (EGD)
A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope.
18 $78 $713
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
14 $106 $851
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$57,712
Total received (2018-2024)
Avg $8,245/year across 7 years
Top 21% in CA for hepatology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
599
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$48,037 (83.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,280 (12.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,395 (4.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,771
2023
$7,015
2022
$4,704
2021
$11,151
2020
$9,273
2019
$12,452
2018
$8,347

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$3,765
GlaxoSmithKline, LLC.
$233
Boston Scientific Corporation
$197
AstraZeneca Pharmaceuticals LP
$138
Gilead Sciences, Inc.
$131
Janssen Biotech, Inc.
$99
Ardelyx, Inc.
$53
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$50
UCB, Inc.
$42
Fresenius Kabi USA, LLC
$34
ABBVIE INC.
$30
Top 3 companies account for 87.9% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan Inc.
$19,109
AbbVie Inc.
$10,824
Horizon Therapeutics plc
$6,929
Amgen Inc.
$3,831
ABBVIE INC.
$3,327
Nestle HealthCare Nutrition Inc.
$3,288
Gilead Sciences, Inc.
$2,987
Allergan, Inc.
$1,524
Janssen Biotech, Inc.
$1,235
GlaxoSmithKline, LLC.
$995
Boston Scientific Corporation
$487
AstraZeneca Pharmaceuticals LP
$482
E.R. Squibb & Sons, L.L.C.
$340
Takeda Pharmaceuticals U.S.A., Inc.
$334
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$249
AbbVie, Inc.
$231
UCB, Inc.
$207
Intercept Pharmaceuticals, Inc.
$198
Synergy Pharmaceuticals Inc
$176
Janssen Scientific Affairs, LLC
$155
Ironwood Pharmaceuticals, Inc
$138
Celgene Corporation
$83
Ardelyx, Inc.
$77
PFIZER INC.
$74
Novartis Pharmaceuticals Corporation
$68
Horizon Pharma plc
$63
Dova Pharmaceuticals
$40
Daiichi Sankyo Inc.
$39
Aurinia Pharma U.S., Inc.
$37
Fresenius Kabi USA, LLC
$34
Ultragenyx Pharmaceutical Inc.
$23
Bioventus LLC
$20
Shionogi Inc
$20
IRONWOOD PHARMACEUTICALS, INC
$18
Merck Sharp & Dohme Corporation
$18
Merck Sharp & Dohme LLC
$17
GENZYME CORPORATION
$17
RedHill Biopharma Inc.
$15
Top 3 companies account for 63.9% of all-time payments
Associated products mentioned in payments ›
APRISO · Agile Esophageal · Amitiza · Axios · BENLYSTA · CREON · Cimzia · Creon · DIFICID · DUEXIS · DUPIXENT · Doptelet · ENTYVIO · EXALT Model D · Enbrel · Entyvio · GELSYN-3 · GENERAL - BILIARY DEVICES · General - Biliary Devices · HUMIRA · Humira · IBSRELA · IDACIO · ILARIS · INJECTAFER · KRYSTEXXA · LINZESS · LUPKYNIS · Linzess · MAVYRET · MOTEGRITY · Mavyret · Mulpleta · OCALIVA · ORENCIA · ORISE · Otezla · Prolia · RAYOS · REMICADE · RINVOQ · Resolution 360 ULTRA Clip · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPYGLASS · STELARA · Spyglass · TEPEZZA · TREMFYA · Talicia · Trulance · UPLIZNA · VIBERZI · Vemlidy · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · ZINPLAVA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (83%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hepatology physician and does not inherently indicate bias, but patients may wish to be aware.

Looking for a hepatology physician in Fresno?
Compare hepatology physicians in the Fresno area by procedure volume, costs, and industry payment transparency.
Browse hepatology physicians nearby

Geographic Context

Hepatology physicians within 10 mi
4
Per 100K population
0.4
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mittal is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mittal experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Mittal performed 484 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mittal receive payments from pharmaceutical companies?
Yes. Dr. Mittal received a total of $57,712 from 38 companies across 599 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mittal's costs compare to other hepatology physicians in Fresno?
Dr. Mittal's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mittal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →